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ABSTRACT 
Context: Skin Cancer is of growing public health concern. The incidence and 
mortality of skin cancer continues to rise. The morbidity and mortality from skin 
cancer is directly proportional to the depth of invasion of the tumor. Primary care 
physicians are in an optimum position to diagnose skin cancer due to their 
frequent exposure to patients. However, it is not clear if primary care physicians 
have adequate knowledge or diagnostic ability to detect skin cancer. Additionally 
it is not clear if primary care physicians are screening or counseling high- risk 
patients. 
Objectives: To assess primary care physicians' knowledge, attitudes, and behavior 
concerning early detection and prevention of skin cancer, and to assess changes in 
primary care physicians' knowledge, attitudes, and behavior following 
implementation of a brief educational intervention developed by the authors. 
Design: Prospective Randomized Controlled Trial 
Setting and Participants: Family medicine and internal medicine residency 
programs (9 total) in acadeJ.?ic and community based settings were randomized to 
control or intervention groups. Participants from both groups (17 4 total) 
completed an initial survey to assess baseline knowledge, attitudes, and behavior 
with regards to early detection and prevention of skin cancer. The control groups 
attended their normal conference while the intervention groups attended a skin 
cancer education module. The same survey was completed again at 2-4 weeks 
follow up by 88 of the original174 participants. Ofthe 88 participants who 
completed both surveys, 43 were in the intervention group and 45 were in the 
control group. Baseline and follow up surveys were analyzed. 
Intervention: 1-hour educational presentation covering skin cancer epidemiology, 
diagnosis, decision-making, screening, and counseling. A copy of the 
presentation and additional educational materials provided to participants can be 
found in appendix 1. 
Main Outcome Measures: Participant survey responses at baseline and follow-up. 
The survey found in appendix 2 tested skin cancer knowledge, diagnostic ability, 
attitudes, and behavior. 
Results: The baseline survey revealed primary care physicians' deficiencies in 
general skin cancer knowledge and diagnostic ability. 28% knew the lifetime risk 
of melanoma for someone in the year 2000 and 18% correctly identified 3 out of 3 
melanomas. 43% knew all four of the ABCD's of melanoma, and 18% listed at 
least 5 risk factors for skin cancer. Following the educational intervention, 
participants in the intervention group gained significant knowledge and diagnostic 
ability. Participants in the intervention group scored significantly better on: 3 of 6 
general skin cancer knowledge questions, listing the ABCDs of melanoma, and 
listing risk factors of melanoma. Parti,cipants in the intervention group correctly 
diagnosed 2 of the 3 melanomas more frequently than those in the control group. 
Primary care physicians in the intervention group reported performing skin cancer 
preventive or early detection measures with new or high-risk patients more often 
than those in the control group. 
Conclusions: Primary care physicians possess inadequate knowledge, diagnostic 
skills, and preventive behaviors with regards to skin cancer prevention and early 
detection that can be improved using a brief educational intervention. 
Introduction 
Skin cancer affects more than one million people a year in the United States 
and is a growing public health concern. Skin cancer incidence rates and mortality 
rates have been rising despite public health efforts. The depth of invasion of skin 
cancer is directly related to morbidity and mortality. Therefore, lesions that are 
diagnosed at an earlier stage may be less likely to cause significant morbidity or 
mortality than lesions diagnosed at a later stage. 
Primary care physicians see a large proportion of the population each year and 
are in a position to be able to diagnose thinner lesions. However primary care 
physicians must possess adequate diagnostic ability to distinguish cancerous and 
pre-cancerous lesions from benign lesions. In addition primary care physicians 
must recognize the risk factors for skiu cancer so they can appropriately stratify 
patients into groups that require further intervention (screening or counseling). 
Some studies suggest that primary care physicians have difficulty diagnosing skin 
lesions. In addition primary care physicians are not screening and counseling 
patients at high risk for skin cancer. A lack ofJa:owledge and skills contributes to 
the lack of screening and counseling performed by primary care physicians. An 
effective educational module may improve the knowledge, attitudes, and 
behaviors of primary care physicians. If successful, these improvements may 
decrease the morbidity and mortality from skin cancer in the United States. 
Epidemiology 
Skin cancer can be classified into three main types based upon the involved 
skin cell type: basal cell carcinoma, squamous cell carcinoma, and melanoma. 
Each type is biologically and epidemiologically distinct. Basal cell carcinoma 
(BCC) is the most common skin cancer while squamous cell carcinoma (SCC) is 
the second most common. Collectively squamous cell and basal cell carcinoma 
are referred to as non-melanoma skin cancer (NMSC). Even though melanoma is 
the least common of the three, it causes significant mortality. 
An estimated 900,000 new cases of basal cell carcinoma occur each year (I). 
The incidence rate of BCC is rising, with one study demonstrating an 80% 
increase between 1980 and 1994 in the northeastern United States (2). Additional 
studies show increases in incidence ofBCC in the US, Europe, and Australia (1,3-
4). BCC usually presents as a pearly papule with a semi-transluscent raised 
border with overlying fine telangiectasias. Although BCC usually occurs on the 
face and neck, as many as 20% may occur in non-sun exposed areas of the body 
(5). One study of over 1500 BCCs showed the following site distribution: nose 
25%, periorbital area 7%, lips 4%, ears 3%, other parts of the face 29%, neck 11% 
and trunk 15% (6). Fortunately, BCC is usually a slow growing, locally invasive 
tumor that rarely metastasizes. Incident rates of metastasis _range from .0028% to 
.1 %(7-9). BCC can invade locally causing significant morbidity and 
disfigurement, especially when located on the face. Given the large, increasing 
incidence rate ofBCC and its ability to cause significant morbidity, primary care 
physicians play an important role in diagnosing these lesions. Risk factors for 
BCC include fair skin, increased cumulative sun exposure, and having a previous 
BCC; 45% of people with one BCC will develop another within 5 years (10). 
Squamous cell carcinoma (SCC) comprises approximately 20% of the greater 
than 1 million new diagnoses of skin cancer each year (1 ). Paralleling that of 
BCC, the incidence rates of SCC are also increasing. One study in the 
northeastern US showed the incidence rate ofSCC increased by 235% for men 
and by 350% for women between 1980 and 1994. Another study in Minnesota 
ccshowed the annual sec age adjusted incidence rates per 100,000 people rose 
from 46 in women and 136 in men (1984-1986) to 100 in women and 156 in men 
(1990-1992). Similar increases have been seen in Australia and the UK (3,11-12). 
SCC usually presents as a hyperkeratotic erythematous to skin colored nodule or 
plaque with an ulcerated center. Development of SCC is related to both increased 
cumulative snn exposure and increased age. Unlike BCC, SCC has a higher rate 
of metastasis, with estimates ranging from 1 to 20% (13-14). Primary care 
physicians again have a role in diagnosing sec early in its course to prevent 
lesions from causing excessive local damage or metastasizing. 
Although melanoma is the least prevalent of the three main types of skin 
cancer, it accounts for 80% of the deaths from skin cancer. The American Cancer 
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Society estimates that in 2002, 53,600 Americans will be diagnosed with invasive 
melanoma and 7,400 Americans will die from the disease (15). This incidence of 
melanoma has increased 4% in the last year (15). Furthermore the incidence of 
melanoma in the US has tripled over the last 22 years (15). Excluding other skin 
cancers, melanoma is currently the fifth most common cancer in men and the 
sixth most common cancer in women in the US (15). Melanoma is also the most 
common cancer in women between the ages of25 and 29 (15). The incidence rate 
of melanoma has risen sharply. In 1935 an American's lifetime risk of 
developing melanoma was 1/1500 (16). Current estimates suggest that the 
lifetime risk of developing melanoma for an American is 1/68 (15). 
Unfortunately, the mortality rate from melanoma has also been rising. The 
Surveillance, Epidemiology, and End Results Program (SEER) has shown a 
32.7% increase in mortality rates between 1973 and 1995 (17). Prognosis of a 
primary lesion depends greatly upon the tnmor depth at diagnosis. The five year 
survival rate for primary tumors without metastasis is >95% when the lesion is< 
.76 mm and approximately 50% when the lesion is> 4mm . 
. Primary Care Physicians 
Primary care physicians (PCPs) have ongoing contact with the majority of the 
US population. This gives PCPs an opportunity to detect skin cancer at its earliest 
stages. PCPs may also counsel patients on skin cancer prevention measures. 
Primary care physicians regularly examine over 70% of the US population. The 
average American visits a primary care physician 1.7 times per year (18). Many 
fewer people see dermatologists regularly. A stndy of patients diagnosed with • 
melanoma showed that 87% of the patients had primary care physicians and 63% 
of the patients had seen a physician within the year prior to their diagnosis with 
melanoma. Only 20% of the patients had seen a dermatologist in the past (19). 
Even though primary care physicians have access to the US population, they 
may not have the tools needed to diagnose skin cancer lesions. In a study by 
Cassileth eta!., only 12% of 105 non-dermatologists were able to diagnose 5 of 6 
melanomas presented as photographs (compared to 69% of dermatologists) (20). 
In the same study, only 38% of primary care physicians correctly diagnosed 4 of 
the 6 melanomas (20). 
The role of the primary care physician in screening for skin cancer is a matter 
of some controversy. Although primary care physicians may have an important 
role in correctly diagnosing pre-cancerous and cancerous lesions, that does not 
··-necessarily mean that primary care physicians should screen their entire patient 
population for skin cancer. Even though the American Academy of Dermatology 
and The American Cancer Society recommend periodic skin exams by physicians, 
the US Preventive Services Task Force has found insufficient evidence to 
recommend FOR or AGAINST routine screening exams (21). This comes from 
the lack of randomized controlled trials that show screening of the general 
population reduces the morbidity or mortality from skin cancer. A randomized 
controlled trial of a population based early detection program is being planned in 
Queensland, Australia. Due to the large number of people who will need to be 
emolled and followed, and the time needed for follow-up, this trial will not 
conclude until 2010 (22). 
Limiting screening to only high-risk patients may be a feasible option. A 
recent cost-effective analysis of screening high-risk patients showed an 
incremental cost-effective ratio of $29,170 per year of life saved (23). This figure 
is less than the often used "cost effective cut-off" of$50,000 per year of life 
saved and also less than $46,410 per year oflife saved by pap smears done every 
3 years (23). 
Thus primary care physicians may choose to screen, in addition to counsel, 
their high-risk patients with regard to skin cancer. Performance rates of 
counseling and screening high-risk patients are low. A study examined data on 
skin cancer counseling and skin examinations that was obtained from 
representative visits to outpatient physicians in the United States from the 1997 
National Ambulatory Medical Care Survey (24). This survey included records of 
703 million outpatient visits in 1997. For this study, high-risk patients where 
defined as patients who had a personal history of a skin cancer or a pre-cancerous 
lesion. Family Physicians documented providing skin cancer prevention 
counseling at 24% of the visits by "high-risk" patients (24). Internal medicine 
physicians documented providing skin cancer prevention counseling at 7. 7% of 
the visits by "high-risk" patients (24). In the same study, screening practices of 
primary care physicians were examined. The frequency that physicians 
documented examining the skin of"high-risk" patients was analyzed by specialty. 
Documented skin exams were performed by family physicians on these "high-
risk" patients only 27% of the time (24). Internal medicine physicians 
documented performing skin exams on these "high-risk" patients 0% of the time 
(24). This lack of screening and counseling may be attributed to primary care 
physicians' lack of knowledge and diagnostic abilities. Other explanations could 
also include lack of time, inappropriateness for the type of visit, or lack of 
documentation. 
Many primary care physicians are interested in improving their knowledge 
and skills in skin cancer detection. In a survey used to assess what type of 
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education primary care physicians felt they needed in North Carolina, physicians 
listed screening for skin cancer, diagnosis of skin cancer, and prevention of skin 
cancer as a high priority (25). 
Working with the North Carolina Advisory Committee on Cancer 
Coordination and Control and in collaboration with Martin Weinstock, MD/PhD, 
,,, the author and a colleague developed "Skin Cancer Prevention and Early 
Detection: Strategies and Skills", a continuing medical education module for 
primary care clinicians. To test the effectiveness of this module in improving 
knowledge and skills for skin cancer detection and management, we designed a 
randomized controlled trial of primary care residency programs, using a pre/post 
survey to measure change. 
The aims of the study are to: 1) assess primary care physicians' knowledge, 
attitudes, and behavior with regard to early detection and prevention of skin 
cancer; and 2) assess changes in primary care physicians' knowledge, attitudes, 
and behavior following implementation of a brief educational intervention. 
Methods 
Design and Setting 
We performed a prospective randomized controlled trial on 9 internal and family 
medicine residency programs set in both the academic and community setting. 
Following IRB approval from the UNC SPH, an email was sent to all residency 
directors of the 15 Family Medicine and Internal Medicine programs in North 
Carolina with greater than 23 residents, inviting them to participate in the study. 
Nine programs (3 Family Medicine and 6 Internal Medicine) agreed to participate 
and were randomized to receive the intervention or control using a random 
number generator. We informed the programs of the group to which they were 
randomized and we scheduled a date for the initial visit. We made all visits 
during residency programs normal "noon conferences." These are conferences 
that residents usually attend every week -day at which different educational topics 
are presented to them"' The principal investigators visited all nine sites together 
for the initial visit, during which we informed all ofthe participants that attended 
"noon conference" on the day of our initial visit of the purpose and requirements 
of our study. We obtained signed informed consent from nearly 100% of the 
attendees at the initial visit. A few attendees did not complete the survey because 
they were paged away from the conference early. 
Intervention 
We developed a module to educate physicians on early detection and prevention 
of skin cancer (appendix 1 ), consisting of a presentation with 80 slides. The 
module incorporated the Basic Skin Cancer Triage Algorithm developed by 
Weinstock (30). An information folder was assembled that contained: a handout 
of the presentation, a copy of the Basic Skin Cancer Triage Algorithm, a self 
administered melanoma risk stratification questionnaire, and a pamphlet entitled 
"Why You Should Know About Melanoma" from the American Cancer Society 
(appendix!). We developed the module to be a continuing medical education 
(CME) course for physicians in North Carolina sponsored by The North Carolina 
Advisory Committee on Cancer Coordination and ControL 
Data Collection 
We developed a 48-question survey that tests: general skin cancer knowledge, 
skin lesion diagnostic ability, attitudes toward skin cancer prevention and early 
detection, and behaviors toward skin cancer prevention and early detection. After 
obtaining informed consent at the initial visit, the participants completed the 10-
minute survey. Following collection of all surveysrthe groups randomized to 
intervention received the information packet and observed our presentation on 
early detection and prevention of skin cancer for the primary care physician. 
Following collection of all surveys at the control sites, the normal "noon-
conference" scheduled for that day proceeded. 17 4 participants completed the 
initial survey. 2 to 4 weeks following the initial visit, the authors returned to 
another "noon-conference" at each site. At the return visit we asked the 
participants to fill out the same survey once again to test the effectiveness of our 
intervention. Of the 174 participants that filled out the initial survey, 88 (51%) 
filled out the post survey. Of the 88 participants who completed both the initial 
and follow-up survey, 43 (49%) were in the intervention group, and 45 (51%) 
were in the control group. We attribute much of the drop out to the fact that 
many of the participants who filled out the initial survey were not at the "noon 
conference" when we returned for follow-up. 
Data Analysis 
I performed initial analysis on all of the baseline survey results. 
Additionally I performed analysis on the baseline and follow up survey results for 
the control and intervention groups. 
For the initial baseline survey results I determined participant 
characteristics and used counts and proportions to characterize the categorical 
variables (multiple-choice questions). I used Pearson's Chi-square test to 
measure associations between participant characteristics and correct answers on 
the multiple-choice questions. I calculated medians and standard deviations for 
continuous variables. 
I next compared initial responses to the multiple choice questions to follow-up 
responses. I calculated counts and proportions of the participants who responded 
correctly at both times. I used Fishers exact test to test ifthe proportions of correct 
answers were different between intervention and control groups in the baseline 
and the follow-up survey. For the continuous variables, I calculated means and 
standard deviations for the intervention and control groups at both baseline and 
follow-up. I used Students t -test to determine if the responses between 
intervention and control groups differed at baseline or at follow-up. All t-tests 
used were 2 sided with an alpha level of .05. I performed statistical analyses 
using Intercooled Stata version 6.0. 
Results 
Characteristics of Participants 
Table 1 shows the baseline characteristics of all participants completing the 
initial survey. Faculty (5%) and medical students (9%) made up a small 
proportion of those filling out the survey; medical residents (86%) made up the 
majority. 46% of those completing the survey were in an academic medical 
setting and 54% were in a community based medical setting. 75% of the 
respondents were in internal medicine residency programs; 25% were in family 
medicine residency programs. 4 5% of those responding had completed a clinical 
dermatology rotation lasting greater than 2 weeks during their training while 55% 
had not. 50% of the respondents anticipated having a clinical dermatology 
rotation lasting greater than 2 weeks before completing training. 51% of the 
respondents reported primary care as their career choice, while 49% were 
planning on subspecialty training or were undecided. 
BASELINE SURVEY RESULTS: 
The initial survey consisted of 6 sections: general skin cancer knowledge; 
diagnostic ability; knowledge of physical exam characteristics and skin cancer 
risk factors; attitudes toward skin cancer prevention and early detection; behavior 
when interviewing a "high-risk" or new patient; and participant demographics. I 
will examine each in sequence. 
Knowledge 
Table 2 shows questions and responses to the general knowledge questions. 
Correct answers are highlighted in bold. Eighty-five percent of respondents 
correctly reported that the most common cancer presenting to the primary care 
physician was skin cancer. However, 15% reported that lung, breast, or colon 
cancer presented more often to primary care physicians than skin cancer, when in 
fact all combined do not present as often as skin cancer. Eighty-five percent of 
respondents correctly identified actinic keratosis as a pre-cancerous lesion. 
Participants who had a clinical dermatology rotation lasting greater than 2 weeks 
were more likely to identifY actinic keratosis as a pre-cancerous lesion (OR 3.08 
95%CI 1.19-7 .92) than those who had not. Only 60% of respondents correctly 
identified basal cell carcinoma as the most common skin cancer, while 33% 
incorrectly identified squamous cell carcinoma and 7% incorrectly identi,fied 
melanoma as the most common skin cancer. Participants who had a clinical 
dermatology rotation lasting greater than 2 week were more likely to identifY 
basal cell carcinoma as the most common type of skin cancer (OR 2.19 95% CI 
1.17-4.12) than those who had not. 59% of respondents underestimated the 
lifetime risk of developing melanoma, while 30% correctly identified the current 
lifetime risk of 1174. 40% of respondents under estimated the 5 year mortality 
rate for a melanoma that is< .75 mm thick and 18% over estimated the 5 year 
mortality rate for a melanoma that is > 4 mm thick. 
Diagnostic ability and decision making 
The next section evaluated the participants' ability to diagnose skin lesions. 
Results for these questions are found in table 3 with correct answers highlighted 
in bold. Section 2 also evaluated the physician's decision-making skills. The 
definitions for the answers to "What would you do next?" are as follows: a. Act 
(biopsy and/or refer), b. Reassure the patient and provide counseling and 
education, c. Track (Reevaluate in 2 months to look for change in the lesion), d. 
Perform cryotherapy and follow up. Pictures of the lesions corresponding to each 
question can be found in appendix 2. 
60% correctly identified lesion A as a melanoma. 99% of those who correctly 
chose melanoma reported they would "act" on the lesion. However, only 74% of 
all participants would have "acted" on the lesion. Only 32% of those surveyed 
correctly identified lesion D as a melanoma. Close to 7 out of 10 would have 
misdiagnosed this cancer. 99% of those who correctly chose melanoma reported 
they would "act" on the lesion. However, only 47% of all participants would have 
"acted" on the lesion. Disturbingly, 16% of respondents would have "reassured" 
the patient with this melanoma. 80% correctly identified lesion F as a melanoma. 
99% of those who correctly chose melanoma reported they would "act" on the 
lesion. However, only 88% of all participants would have "acted" on the lesion. 
In total, only 31 of 173 (18%) respondents correctly identified 3 out of 3 
melanomas. 98/173 (57%) correctly identified 2 of3 melanomas and 167 out of 
173 (97%) correctly identified 1 of3 melanomas. 88% correctly identified lesion 
B as a basal cell carcinoma and 84% chose to act on this lesion. 93% of 
respondents who correctly chose basal cell carcinoma decided to "act" on the 
lesion. 89% correctly identified lesion Cas a nevus. 53% chose to "reassure" 
these patients. 67% correctly identified lesion D as a seborrheic keratosis and 
45% chose to "reassure" these patients. Participants who had a dermatology 
rotation were more likely to correctly identify the seborrheic keratosis. (OR-1.8 
95%CI 0.95-3.5) 
Knowledge of The ABCD 's of Melanoma 
In this section participants were asked to list 4 physical exam characteristics 
of a skin lesion that would suggest melanoma. Results are found in table 4. 54% 
correctly identified assymetry, 89% correctly identified border irregularity, 89% 
correctly identified color variation, and 75% correctly identified large diameter as 
suggestive of melanoma. Only (75/173) or 43% of participants listed a114 of the 
characteristics. 75% listed 3 of the 4 characteristics and 88% listed 2 of the 4 
characteristics. 
Knowledge of The Risk Factors for Skin Cancer 
Participants were asked to list risk factors for skin cancer. The results are 
shown in table 5. 96% listed excessive sun exposure and 67% listed family history 
of skin cancer. Only 57% listed fair skin and only 24% listed personal history of 
skin cancer. 29% listed a history of blistering sunburns and 20% listed genetics. 
Participants who had a dermatology rotation were more likely to list genetics as a 
risk factor (OR 2.12 95%CI .986-4.55). Less than 10% listed 
immunosuppression, large congenital nevi, dysplastic nevi, actinic keratosis, or 
lentigo maligna 100% listed at least I risk factor for skin cancer, 91% listed at 
least 2 and 68% listed at least 3. Only 39% listed at least 4 and 18% listed at least 
5 risk factors. Few ( 5%) listed 6 or more risk factors. 
Attitudes toward skin cancer prevention and detection 
In this section participants were asked to evaluate statements regarding 
attitudes on skin cancer prevention and detection. Participants felt that early 
detection of skin cancer can improve morbidity and mortality. They also felt that 
lack of time and lack of education limited skin cancer prevention and early 
detection. Participants also felt that patients desire counseling, and that 
counseling can be effective. 
Physician behavior at a visit with a "high-risk" patient 
In this section participants were asked to evaluate statements that tested 
behaviors at a visit with a "high-risk" patient. Table 7 shows results. Participants 
reported that they infrequently performed total body skin exams, ask about the use 
of sunscreen, or advice or counsel on skin cancer risk. 
Physician behavior at a visit with a "new" patient 
In this section participants were asked to evaluate statements that tested 
behaviors at a visit with a "new" patient. Participants infrequently ask patients if 
they regularly examine their skin for growths or changes in lesions, ask about a 
personal or family history of melanoma, ask if patients use sunscreen regularly or 
ask about a history of blistering sunburns. Participants infrequently advise the use 
of sunscreen, advise midday sun exposure, advise to use hats or other protective 
clothing, or advice to perform regular skin examinations .for growths or changes 
in spots. 
FOLLOW-UP SURVEY RESULTS 
Of the 174 participants who filled out the initial survey, 88 also filled out the 
follow up survey. Of these 88 participants, 43 were in the intervention group and 
45 were in the control group. 1bis section will examine the differences in 
responses at baseline and follow-up between the participants in the control and 
~ intervention groups. The results are presented comparing 1ntervention and control 
groups at baseline and follow up. For sections "General Knowledge", 
"Diagnostic ability and decision making", "ABCD's of Melanoma", and "Risk 
Factors for skin cancer" the proportion answered correctly by intervention and 
control groups was compared at baseline and follow up. If the proportion correct 
in the intervention and control groups are similar at baseline but different at 
follow up (higher in the intervention group), then the intervention did have an 
effect. If the proportion correct in intervention and control groups are similar at 
baseline and at follow up, then the intervention did not have an effect. If the 
proportion correct in intervention and control groups are different at baseline, then 
no, conclusion can be made about the intervention. For the remaining sections, the 
means at baseline and follow up were compared between intervention and control 
group. If the difference in the intervention group was significantly different from 
the difference in the control group, then the intervention had an effect. 
Knowledge 
Participants' responses at baseline and follow up to the general skin cancer 
knowledge questions are found in Table 9. The results are presented comparing 
baseline and follow up responses by study group. For the general knowledge 
questions, participants in the intervention group performed better at follow up in 
answering 3 of the 6 questions. Participants in the intervention group were more 
likely to respond correctly to questions about lifetime risk of melanoma and 5-
year survival rates for thin and thick lesions. 
Diagnostic ability and decision making 
Participants' responses at baseline and follow up to the diagnostic ability and 
decision making are found in Table 10. Participants in the intervention group 
performed better at identifYing 2 of the melanomas at follow up and were more 
likely to "act" on the diagnosis 
Knowledge of The ABCD 's of Melanoma 
Participants' responses at baseline and follow up to the knowledge of the · 
ABCD's of melanoma are found in table 11. Although results were not 
statistically ~ignificant, participants in the intervention group listed all four of the 
characteristics more often than those in the control group at follow up. 
Knowledge ofThe Risk Factors for Skin Cancer 
Participants' responses at baseline and follow up to the risk factors for skin 
cancer are found in table 12. The results are broken down comparing intervention 
versus control and baseline versus follow up. Participants in the intervention · 
group performed better at follow up than those in the control group in listing 7 of 
the risk factors for skin cancer: personal history of skin cancer, high number of 
common nevi, history of blistering sunburns, presence of a dysplatic nevi, 
presence of a actinic keratosis, presence of a large congenital nevi, and presence 
of a lentigo maligna. 
Attitudes toward skin cancer prevention and detection 
Participants' responses at baseline and follow up regarding their attitudes 
toward skin cancer prevention and detection can be found in Table 13. The 
participants' change in response between baseline and follow up for both the 
intervention and control groups can be found in Table 13A. The change in 
response between baseline and follow up was significant for two statements: 
"Total body self exam is effective," and "I am confident in my abilities to 
diagnose skin lesions." 
Physician behavior at a visit with a "high-risk" patient 
Participants' respqnses at baseline and follow up regarding their behavior at a 
visit with a "high-risk" patient can be found in Table 14. The participants' 
change in response between baseline and follow up for both the intervention and 
control groups can be found in Table 14A. At follow up participants in the 
intervention group were more likely than participants in the control group to 
report higher frequencies of performing these stated behaviors: performing a total 
body skin exam, asking about the use of sunscreen, providing advise and counsel 
about skin cancer risk, and providing resource materials on skin cancer. 
Physician behavior at a visit with a "new" patient 
Participants' responses at baseline and follow up regarding their behavior at a 
visit with a "new" patient can be found in Table 15. The participants' change in 
response between baseline and follow up for both the intervention and control 
groups can be found in Table 15A. At follow up participants in the intervention 
group were more likely than participants in the control group to report higher 
frequencies of performing these stated risk stratifying behaviors: asking about a 
history of melanoma, asking about a family history of melanoma, asking about a 
history of tanning bed use, asking about sunscreen use, and asking about a history 
of blistering sunburns. Participants in the intervention group were also more 
likely to provide written materials about skin cancer prevention, and provide sun 
safety counseling. 
Discussion 
In this study conducted in Iqternal Medicine and Family Medicine residency 
training programs, we found significant deficiencies in knowledge and diagnostic 
abilities of primary care physicians with regard to skin cancer. Other similar 
studies have also documented lack of knowledge and diagnostic skills in primary 
care physicians. Stephenson found that more than 50% of family physicians 
lacked confidence in being able to recognized melanoma, 30% were not confident 
in their ability to diagnose basal cell carcinoma, and greater than 50% were not 
confident in their ability to diagnose squamous cell carcinoma or dysplastic nevi 
(26). 
Additionally, physicians in this study had difficulty correctly identifying skin 
cancers in photographs. In a similar study that only 12% of 105 non-
dermatologists were able to diagnose 5 of 6 melanomas presented as photographs 
(compared to 69% of dermatologists) (20). In the same study only 38%·of 
primary care physicians correctly diagnosed 4 of the 6 melanomas (20). An 
additional study that used pictures oflesions found that primary care physicians 
correctly diagnosed melanoma 50% of the time (27). Bedlow and Ward have also 
documented knowledge and diagnostic deficiencies in primary care physicians 
(28-29). 
This study contributes to the growing literature supporting a lack of 
knowledge and diagnostic ability about skin cancer in many primary care 
physicians. This may lead to fewer activities for prevention and early detection of 
skin cancer. Physicians who do not know risk factors may not accurately risk 
stratify their patients. Physicians who ar~ not confident in their ability to 
diagnose skin lesions may be less likely to examine the skin. We found that 
participants who had a clinical dermatology rotation of greater than 2 weeks had 
higher levels of knowledge about skin cancer. Finding ways to include more 
exposure to dermatology during residency training may be an important step in 
improving physicians' abilities. CME activities, such as this educational module, 
may also be important for practicing physicians. 
This study also showed that a brief educational module could increase primary 
care physicians' knowledge and diagnostic abilities. It also changed self-reported 
skin cancer prevention behaviors. Similar educational interventions have been 
attempted with mixed results. Much of this curriculum was based on work by 
Martin Weinstock, MD, PhD (30-32), who showed significant increases in 
provider self-reported skin cancercontrol practices during an initial visit with an 
new patient and during a routine visit with a high risk patient following a similar 
2-hour curriculum (31). In his similar but smaller study (22 participants) self-
reported behavior by the participants was confirmed by exit interviews with 
patients. This showed that participants self-reports were reliable in this setting 
and agreed with patients' reports. They also showed increases in diagnostic 
ability and triage practices following the similar 2-hour curriculum (32). Other 
interventions have not been as successful. Dolan only found modest effects on 
skin cancer control attitudes, beliefs, knowledge, and behaviors following a brief 
educational intervention that was presented to internal medicine housestaff and 
faculty in one large academic setting (33). The difft;_rence between the positive 
results garnered by us and Weinstock and the negative results from Dolan may be 
attributed to the nature of the educational module. We based much of our 
curriculum on the one developed by Weinstock. The module used by Dolan is not 
discussed thoroughly in the paper. One difficulty in educating busy physicians is 
finding a time that is optimum for many of them to congregate. Some researchers 
have dealt with this by developing 'internet based' educational modules. One on-
line education class caused significant improvement in physician confidence, 
knowledge, and skills related to skin cancer prevention and early detection (34). 
This study adds to the growing literature that educational interventions targeted to 
increase physician knowledge, attitudes, and behavior with regards to skin cancer 
prevention and early detection can be successfuL 
The limitations of this study include the background of the participants, the 
-''drop-out rate, and follow-up time. The participants were mainly composed of 
medical residents in family medicine and internal medicine residency programs in 
North Carolina. They were chosen because they were a convenient sample. 
Optimally one would like to survey the knowledge, attitudes, and behaviors of 
actual primary care physicians who have completed training and are practicing in 
the community_ However, it is difficult to bring together a large number of 
practicing physicians for an intervention. Another limitation is the large drop-out 
rate. Of the 174 participants who completed the initial survey, only 88 (51%) 
completed the follow up survey_ There may be a selection bias as to which 
participants chose to fill out the follow up survey. Optimally one would want a 
much higher follow-up rate. A third limitation is follow-up ti.me. The follow-up 
surveys were given 2-4 weeks following the initial visit The changes found in 
the intervention group at follow-up may not be lasting. Longer follow-up time 
using similar interventions are needed. An additional limitation is that the 
behaviors of primary care physicians were self-reported. 
Further research is needed in assessing knowledge and behaviors of primary 
care physicians with regard to skin cancer prevention and detection. Specifically, 
the ability of primary care physicians to appropriately risk stratifY patients and 
correctly identifY cancerous, pre-cancerous, and benign lesions must be explored. 
If continued deficiencies in these areas continue to appear, more research must be 
applied to better educate primary care physicians in these areas. Additionally 
further research is needed in development and testing of educational modules. 
We need to know what aspects of our curriculum and Weinstock's curriculum 
make them effective whereas Dolan's curriculum was not. We also need to learn '0 ' 
the best way to get effective educational modules 1o many practicing physicians. 
Lastly, further research is needed to determine the effectiveness of screening and 
counseling for early detection and prevention of skin cancer. Whether primary 
care physicians should be actively screening or counseling their patients with 
regard to skin cancer is not known. However, primary care physicians should 
possess general skin cancer knowledge and the ability to diagnose benign, 
cancerous, and precancerous lesions. 
Conclusion: 
Primary care resident physicians possess inadequate knowledge, diagnos_tic skills, 
and preventive behaviors with regard to skin cancer prevention and early 
detection; these deficits can be improved in the short term using a brief 
educational intervention. 
TABLE 1. 
Characteristics of All Participants Completing Initial Baseline Survey 
Characteristic Number(%) 
Level of Training 1st "d 54(32%) year rest ent 
2nd "d 43(25%) year rest ent 
3'd "d 41(24%) year rest ent 
4th year resident 6( 4%)51hyear resident 
2(1%) 
,, Attending 9(5%) 
Medical Student 15(9%) 
Residency Program Setting Academic: 80(46%) 
Community: 94(54%) 
Residency Program Type Internal Medicine: 131(75%) 
Family Medicine: 43(25%) 
Sex Male: 106(62%) 
Female: 66(38%) 
Had a Clinical Dermatology Rotation > 2 Yes: 78(45%) 
weeks Medical Student: 47{27%) 
Resident: 19{!!%) 
Both: !2(7%) 
No: 94(55%) 
Anticipate Having a Clinical Yes: 86(50%) 
Dermatology Rotation> 2 weeks prior to No: 85(50%) 
completing training 
Career Primary Care 87(51%) 
S pecializedl 84(49%) 
Undecided 
TABLE2 
Baseline Survey Results: Basic Skin Cancer Knowledge 
Question Answers: number(%) 
L What is the most common cancer to a. Lung 20(11.63) 
present to a primary care physician? b. Breast 3(1.74) 
c. Colon 3(1.74) 
d. Skin 146(84.88) 
2. Which of the following is a pre· a. Seborrheic keratosis 8(4.68) 
cancerous lesion? b. Dermatofibroma 1(0.58) 
c. Actinic keratosis 145(84.8) 
d. Cafe-au-lait spot 1(0.58) 
e. Dermal nevus 16(9.36) 
3. What is the most common type of skin a. Basal cell 104(59.77) 
cancer? b. Squamous cell 58(33.33) 
c. Dermatofibroma 0(0) 
d. Melanoma 12(6.90) 
4. What is the lifetime risk of developing a. 1/34 24(14.04) 
melanoma in the year 2000? b. 1174 48(28.07) 
c. 1/100 66(38.60) 
d. 1/194 33(19.30) 
5. What is the 5-year survival rate for a a. 40% 0(0) 
melanoma that is less that 1 mm thick? b. 50% 10(5.75) 
c. 80% 59(33.91) 
d. 95% 105(60.34) 
6. What is the 5-year survival rate for a a. 30% 79(45.66) 
primary melanoma lesion that is > 4 b. 50% 63(36.42) 
mm thick without known metastasis? c. 75% 28(16.18) 
d. 90% 3(1.73) 
TABLE 3 
Baseline Survey Results: Diagnostic Ability and Decision Making 
Question: Answers: Number(%)_ 
7a. 40 year old caucasian male with a a. Seborreic Keratosis 9(5.2) 
lesion on his shoulder. (picture A) b. Basal Cell 10(5.78) 
What is the most likely diagnosis? c. Angioma 0(0) 
d. Melanoma 100(57.8) 
e. Nevus 54(31.2) 
7b. What would you do next? a. Act 127(73.84) 
b. Reassure 8(4.65) 
c. Track 36(20.93) 
d. Cryotherapy 1(0.58) 
8a 50 year old male with lesion on his face. a. Seborrcic Keratosis 6(3.45) 
(picture B) d. Basal Cell 152(87.36) 
What is the most likely diagnosis? e. Angioma 4 (2.30) 
d. Melanoma 2 (1.15) 
e. Actinic Keratosis 10 (5.75) 
8b. What would you do next? a. Act 146(83.91) 
d. Reassure 3(1.72) 
e. Track 7(4.02) 
d. Cryotherapy 18(1 0.34) 
9a. 35 year old woman with lesion on her hand. a. Seborreic Keratosis 12(6.90) 
(picture C) b. Basal Cell 0(0) 
What is the most likely diagnosis? c. Angioma I (0.57) 
d. Melanoma 7(4.02) 
e. Nevus 154(88.51) 
9b. What would you do next? a Act 11(6.32) 
b. Reassure 91(52.3) 
c. Track 71(40.86) 
d. Cryotherapy 1(0.57) 
I Oa 45 year old woman with lesion on her ann. a Seborreic Keratosis 4(2.31) 
(picture D) d. Basal Cell 6(3.47) 
What is the most likely diagnosis? e. Angioma 71(41.04) 
d. Melanoma 56(32.37) 
e. Nevus 36(20.8) 
1 Ob. What would you do next? a. Act 81(46.82) 
b. Reassure 28(16.18) 
c. Track 59(34.10) 
d. Cryotherapy s(2.89) 
11a. 55 year old male with lesion on his back. a. Seborreic Keratosis 116(67.05) 
(picture E) f Basal Cell 9(5.20) 
What is the most likely diagnosis? g. Angioma 1(0.58) 
d. Melanoma 15(8.67) 
e. Actinic Keratosis 32(18.5) 
11b. What would you do next? a. Act 42(24.71) 
b. Reassure 77(45.29) 
c. Track 26(15.29) 
d. Cryotherapy 25(14.71) 
12a. 47 year old woman with lesion on her leg. a. Seborreic Keratosis 0(0) 
(picture F) h. Basal Cell 3(1.72) 
What is the most likely diagnosis? i. Angioma 13(7.47) 
d. Melanoma 140(80.46) 
e. Nevus 18(10.34 
12b. What would you do next? j. Act 152(87.86) 
d. Reassure 1(0.58) 
e. Track 19(10.98) 
d. Cryotherapy I (0.58) 
-- --- --- ----- - -- --------------------------~ 
TABLE4 
Baseline Survey Results: Knowledge of the ABCD's of Melanoma 
Physical exam characteristic of melanoma: Number Corre:_:c:_:_t-'-(0'--'YoL)-"(N'--'--=__,_) __ ---:---:---c~ 
Assymetry 54(93) 
Border irregularity 89(154) 
Color variation 89(154) 
Diameter> 6 mm 75(129) 
TABLES 
Baseline Survey Results: Knowledge of Skin Cancer Risk Factors 
Risk Factor for Skin Cancer Number % 
Excessive sun exposure 167 96.63 
Personal history of skin cancer 42 24.28 
Family history of skin cancer 114 65.90 
Genetic diseases (albinism, xeroderma pigmentosa, 34 19.65 
basal cell nevoid syndrome) 
High number (>50) nevi 10 5.78 
Fair skin 99 57.23 
History of blistering sunburns 50 28.90 
Immunosuppression (HIV, chemotherapy) 13 7.51 
Large congenital nevi 4 2.71 
Dysplasti/ Atypical nevus 9 5.20 
Actinic keratosis 14 8.09 
Lentigo maligna 3 1.73 
TABLE6 
Baseline Survey Results: Attitudes Toward Skin Cancer Prevention and Detection 
!=Disagree 2=Somewhat Disagree 3=Neutral 4=Somewhat Agree 5=Agree 
Statement Mean SD 
16. Time is a limiting factor in skin cancer prevention and early detection. 3.63 1.26 
17. Lack of education is a limiting factor in skin cancer prevention and 4.09 1.00 
early detection. 
18. Total body self exam (TBSE) is effective 3.92 .99 
19. Patients do not appreciate efforts to provide information on TBSE 2.44 ... 1.05 
20. Early detection of skin cancer can improve morbidity 4.70 .56 
21. Early detection of skin cancer can improve mortality. 4.72 .61 
22. Physicians cannot be effective in helping patients decrease skin cancer 1.34 .60 
risk. 
23. Patients want counseling about skin cancer prevention. 3.92 .81 
24. Physician advice is one of the best ways of influencing a patient's 3.93 .93 
decision to reduce their risk. 
25. Physician counseling about skin cancer cannot save lives 1.53 .66 
26. I am confident in my ability to diagnose skin lesions 2.62 1.07 
TABLE7 
Baseline Survey Results: Physician Behavior at a Visit with a "High-Risk" Patient 
1 N 2 I fr 1 3 s 40ft SAl A1 = ever =n equent y = ometJmes - en = most ways -
Statement Mean SD 
27. I perform a total body skin exam 2.53 .98 
28. I ask about use of sunscreen 2.62 1.05 
29. I advice and counsel about skin cancer risk 2.72 1.00 
30. I provide resource materials on skin cancer 2.61 .94 
TABLES 
Baseline Survey Results: Physician Behavior at a Visit with a "New" Patient 
1 =Never 2=Infrequently 3=Sometimes 4=0ften 5=Almost Always 
31. I ask patients if they regularly examine their skin for growths or 2.40 .93 
changes in lesions. 
32. I ask about a personal history of melanoma. 2.45 1.03 
33. I ask about a family history of melanoma. 2.47 1.02 
34. l: ask about history of tanning bed use. 2.03 .96 
35. I ask if patients use sunscreen regularly. 2.44 1.02 
36. I ask about a history of blistering sunburns. 2.55 .91 
3 7. I provide written materials about skin cancer prevention. 1.77 .83 
38. I advise use of sunscreen. 2.88 1.09 
39. I advise to avoid midday sun exposure 2.37 1.06 
40. I advise to use hats and other protective clothing 2.59 1.02 
41. I advise to perform regular skin examination for growth or changes in 2.66 1.01 
spots. 
TABLE9 
Follow-Up Survey Results: Basic Skin Cancer Knowledge 
Baseline Follow-Up 
%Correct %Correct 
Intervention Intervention 
Control Control 
p value p value 
Question 
1. What is the most common cancer 85 88 -, .... _, 
to present to a primary care 89 89 
physician? NS NS 
2. Which of the following is a pre- 93 100 
cancerous lesion? 93 93 
NS NS 
3. What is the most common type of 52 69 
skin cancer? 71 77 
(.08) NS 
4. What is the lifetime risk of 28 61 
developing melanoma in the year 22 31 
2000? NS (.005) 
5. What is the 5-year survival rate 73 83 
for a melanoma that is less that 1 53 51 
mm thick? (.07) (.002) 
6. What is the 5-year survival rate 35 52 
for a primary melanoma lesion 37 33 
that is > 4 mm thick without NS (.08) 
. known metastasis? 
, (p value for fisher s exact test) NS~on sJgmficant 
TABLEIO 
Follow-Up Survey Results: Diagnostic Ability and Decision Making 
Baseline Follow-Up 
%Correct %Correct 
Intervention Intervention 
Control Control 
p value p value 
Question 
7a. 40 year old caucasian male with a 69 73 
lesion on his shoulder. (picture A) 53 37-
What is the most likely diagnosis? NS (.001) 
7b. What would you do next? 83 83 
77 60 
NS (.019) 
8a. 50 year old male with lesion on his face. 97 95 
(picture B) 95 91 
What is the most likely diagnosis? NS NS 
8b. What would you do next? 78 83 
91 88 
NS NS 
9a 35 year old woman with lesion on her hand. 83 83 
(picture C) 89 86 
What is the most likely diagnosis? NS NS 
9b. What would you do next? 64 52 
47 40 
NS NS 
lOa 45 year old woman with lesion on her ann. 30 29 
(picture D) 35 29 
What is the most likely diagnosis? NS NS 
lOb. What would you do next? 45 38 
53 40 
NS NS 
lla. 55 year old male with lesion on his back. 69 67 
(picture E) 77 80 
What is the most likely diagnosis? NS NS 
I lb. What would you do next? 55 47 
44 46 
NS NS 
12a. 47 year old woman with lesion on her leg. 78 92 
(picture F) 80 80 
What is the most likely diagnosis? NS (.12) 
12b. What would you do next? 87 95 
93 86 
NS NS 
(p value for fisher's exact test) (NS~Non-slgmficant) 
TABLE 11 
Follow-Up Survey Results: Knowledge of the ABCD's of Melanoma 
Baseline Follow-Up 
%Correct %Correct 
Intervention Intervention 
Control Control 
p value pvalue 
Physical Exam Characteristics of Melanoma 
Assymetry - 64 78 
62 60 
NS NS 
Border irregularity 95 93 
91 86 
NS NS 
Color variation 85 95 
88 84 
NS NS 
Diameter > 6 mm 64 75 
80 66 
NS NS 
NS-Non-stgmficant 
TABLE12 
Follow-Up Survey Results· Risk Factors for Skin Cancer 
Baseline Follow-Up 
%Correct %Correct 
Intervention Intervention 
Control Control 
p value P value 
Excessive sun exposure 95 95 
95 100 
NS ~-·' NS 
Personal history of skin cancer 26 55 
22 33 
NS (.05) 
Family history of skin cancer 69 67 
71 62 
NS NS 
Genetic diseases (albinism, xeroderma 11 12 
pigmentosa, basal cell nevoid syndrome) 20 15 
NS NS 
High number (>50) nevi 7 30 
4 6 
NS (.009) 
Fair skin 61 72 
68 60 
NS NS 
History of blistering sunburns 40 62 
33 31 
NS (.005) 
Immunosuppression (HIV, chemotherapy) 2 7 
• 6 6 
NS NS 
Large congenital nevi 4 !3 
0 2 
NS (.09) 
Dysplasti/ Atypical nevus 2 33 
6 2 
NS (.0001) 
Actinic keratosis 9 23 
11 6 
NS (.05) 
Lentigo maligna 2 !3 
0 2 
NS (.09) 
, (p-fisher s exact test) (NS-Non-s1gmficant) 
TABLE 13 
Follow-Up Survey Results: Attitudes Toward Skin Cancer Prevention and Detection 
1 =Disagree 2=Somewhat Disagree 3=Neutral 4=Somewhat Agree 5=Agree 
Baseline Data: Follow Up Data: 
Mean(SD) Mean(SD) 
Statement Intervention Control Intervention Control 
16. Time is a limiting factor in skin cancer 3.47 3.62 3.70 3:75 
prevention and early detection. (1.28) (1.34) (1.06) (1.05) 
17. Lack of education is a limiting factor in 3.77 4.1 3.93 4.02 
skin cancer prevention and (1.11) (1.04) (.91) (.87) 
early detection. 
18. Total body self exam (TBSE) is effective 3.58 3.89 4.11 3.97 
(1.14) (1.03) (.88) (.84) 
19. Patients do not appreciate efforts to provide 2.33 2.35 2.16 2.16 
information on TBSE (1.00) (1.09) (.87) (.90) 
20. Early detection of skin cancer can improve 4.63 4.73 4.64 4.69 
morbidity (.76) (.44) (.58) (.47) 
21. Early detection of skin cancer can improve 4.65 4.77 4.71 4.69 
mortality. (.78) (.56) (.60) (.60) 
22. Physicians cannot be effective in helping 1.47 1.22 1.60 1.49 
patients decrease skin cancer (.74) (.51) (.87) (.66) 
risk. . 
23. Patients want counseling about skin cancer 3.91 3.87 3.88 3.88 
prevention. (.89) (.84) (.87) (.80) 
24. Physician advice is one of the best ways of 3.95 3.89 4.20 3.93 
influencing a patient's (.95) (.93) (.76) (.86) 
decision to reduce their risk. 
25. Physician counseling about skin cancer 1.70 1.49 1.65 1.64 
cannot save lives (.74) (.69) (.72) (.71) 
26. I am confident in my ability to diagnose 2.91 2.96 3.33** 2.98** 
skin lesions (1.04) (1.07) (.96) (1.02) 
**p value< .10 for fol1ow-up mterventwn versus control score 
TABLE 13A 
Follow-Up Survey Results: Attitudes Toward Skin Cancer Prevention and Detection 
I D. = 1sagree = 2 s h tD. omew a 1sagree h tA 3Ntl4S = eura = omew a gree = 5 A gree 
Change in Response: Difference of Change: 
Mean(SD) Significance of Change 
Statement Intervention Control Difference P value< 
16. Time is a limiting factor in skin cancer .23 .13 .10 .73 
prevention and early detection. (1.32) (1.32) 
17. Lack of education is a limiting factor in .16 -.06 .23 .34 
skin cancer prevention and (1.17) (1.1) 
early detection. 
18. Total body self exam (TBSE) is .53 .09 .45 .05* 
effective (.98) (1.12) 
19. Patients do not appreciate efforts to -.19 -.2 .009 .96 
provide information on TBSE (80) (1.12) 
20. Early detection of skin cancer can -.09 -.04 -.05 .81 
improve morbidity (1.12) (.60) 
21. Early detection of skin cancer can .1 -.01 .189 .28 
improve mortality. (.81) (.82) 
22. Physicians cannot be effective in helping .18 .27 -.08 .58 
patients decrease skin cancer (.79) (.54) 
risk. 
23. Patients want counseling about skin -.02 .02 -.05 .80 
cancer prevention. (.83) (.89) 
24. Physician advice is one of the best ways .23 .04 .19 .32 
of influencing a patient's (1.02) (.73) 
decision to reduce their fisk. 
25. Physician counseling about skin cancer -.05 .15 -.20 .225 
cannot save lives (.75) (.79) 
26. I am confident in my ability to diagnose .43 .03 .40 .047* 
skin lesions (.95) (.89) 
TABLE14 
Follow-Up Survey Results: Physician Behavior at a Visit with a "High-Risk" Patient 
1 =Never 2=Infrequently 3=Sometimes 4=0ften 5=Almost Always 
Baseline Data: Follow Up Data: 
Mean(SD) Mean(SD) 
Statement Intervention Control Intervention Control 
27. I perform a total body skin exam 2.68 2.53 2.67* 2.24* 
(.89) (.97) (.99) - -~ (.70) 
28. I ask about use of sunscreen 2.83 2.44 3.09* 2.4* 
(.97) (.94) (.92) (.89) 
29. I advice and counsel about skin cancer risk 2.95 2.59 3.19* 2.62* 
(.98) (.92) (.86) (.96) 
30. I provide resource materials on skin cancer 2.02 1.84 2.32* 1.71 * 
(.91) (.76) (.92) (.69) 
*p value< .05 for follow-up mterventwn versus control score 
TABLE 14A 
Follow-Up Survey Results: Physician Behavior at a Visit with a "High-Risk" Patient 
1 =Disagree 2=Somewhat Disagree 3=Neutral 4=Somewhat Agree 5=Agree 
Change in Response: Difference of Change: 
Mean(SD) Significance of Change 
Statement Intervention Control Difference P value< 
27. I perform a total body skin exam 0 -.28 .288 .15 
(.90) (.94) 
28. I ask about use of sunscreen .25 -.04 .30 .13 
(.93) (.93) 
29. I advice and counsel about skin cancer .16 .02 .14 .50 
risk (1.21) (.76) 
30. I provide resource materials on skin .3 -.13 .44 .02* 
cancer (1.03) (.73) 
TABLEI5 
Follow-Up Survey Results: Physician Behavior at a Visit with a "New" Patient 
I =Never 2=Infrequently 3=Sometimes 4=0ften 5=Aimost Always 
Baseline Data: Follow Up Data: 
Mean(SD) Mean(SD) 
Statement Intervention Control Intervention Control 
31. I ask patients if they regularly examine 2.6 2.47 2.83 2.53 
their skin for growths or changes in lesions. (.85) (1.07) (.84) (.96) 
' 
. 
32. I ask about a personal history of melanoma. 2.67 2.31 2.95* 2.47* 
(.94) (.97) (.99) (1.01) 
33. I ask about a family history of melanoma. 2.73 2.46 2.93* 2.47* 
(.91) (1.03) (1.03) (1.01) 
34. I ask about history of tanning bed use. 2.21 2.11 2.60* 2.06* 
(1.06) (.88) (.82) (.75) 
35. I ask if patients use sunscreen regularly. 2.65 2.4 2.80** 2.44** 
(.97) (1.03) (.93) (1.06) 
36. I ask about a history of blistering sunburns. 2.18 1.88 2.53** 2.2** 
(.95) (.75) (.91) (.94) 
3 7. I provide written materials about skin 1.85 1.64 2.07* 1.64* 
cancer prevention. (.78) (.77) (.83) (.68) 
38. I advise use of sunscreen. 3.01 2.76 3.25* 2.78* 
(.99) (1.11) (1.00) (1.06) 
39. I advise to avoid midday sun exposure 2.79 2.13 3.09* 2.37* 
(1.01) (1.0 I) (.92) (1.01) 
40. I advise to use hats and other protective 2.95 2.53 3.11** 2.47** 
clothing (.95) (1.12) (.98) (1.07) 
41. I advise to perform regular skin 2.86 2.75 3.2* 2.74* 
examination for growth or changes in (.94) . (1.09) (.94) (1.02) 
spots. 
TABLE 15A 
Follow-Up Survey Results: Physician Behavior at a Visit with a "New" Patient 
1 =Never 2=Infrequently 3=Sometimes 4=0ften 5=Aimost Always 
Change in Response: Difference of Change: 
Mean (SD) Significance of Change 
Statement Intervention Control Difference P value< 
31. I ask patients if they regularly examine .23 .06 .17 .34 
their skin for growths or (.78) (.83) 
changes in lesions. 
32. I ask about a personal history of .28 .15 .12 .56 
melanoma. (1.0) (.97) 
33. I ask about a family history of .17 -.03 .2 .34 
melanoma. (.19) (1.0) 
34. I ask about history of tarming bed use. .39 -.04 .44 .007* 
(.876) (.60) 
35. I ask if patients use sunscreen regularly. .15 .04 .11 .55 
(.77) (.90) 
36. I ask about a history of blistering .35 .31 .04 .83 
sunburns. (.92) (.76) 
3 7. I provide written materials about skin .24 0 .24 .17 
cancer prevention. (.79) (.82) 
38. I advise use of sunscreen. .18 .02 .16 .35 
(.87) (.75) 
39. I advise to avoid midday sun exposure .30 .24 .06 .75 
(.91) (.80) 
40. I advise to use hats and other protective .16 -.05 .21 .23 
clothing (.92) (.77) 
4 L I advise to perform regular skin .34 -.01 .36 .08** 
examination for growth or changes in (1.04) (.88) . 
spots. 
Appendix 1 
• "Skin Cancer Early Detection and Prevention for the Primary Care Physician" 
presentation handout 
• Basic Skin Cancer Triage Algorithm 
• Self Administered Melanoma Risk Stratification Questionnaire 
• "Why You Should Know About Melanoma": Pamphlet from the American 
Cancer Society 
Cancer Prevention and 
Detection: 
Str12te~~ies and Skills 
Jeremy Bordeaux, 
MD,MPH (expected 5/02) 
Cristy Parker, 
MD,MPH (expected 5/02) 
Rationale 
What are we doing here? 
*Primary Care Physicians are not screening 
high risk patients for skin cancer 
-Family Physicians performed skin 
examinations on these patients 27% of the 
time 
-Internal Medicine Physicians perfonned skin 
examinations on these patients 0% of the time 
Rationale 
What are we here? 
*Primary Care Physicians in NC want to 
be educated about skin cancer detection 
and prevention 
- 1999 survey done by the North Carolina 
Advisory Committee on Cancer Coordination 
and Control 
Rationale 
What are we rln;ina here? 
*Primary Care Physicians have difficulty 
diagnosing skin cancer 
- Accuracy of skin cancer diagnosis by specialty 
• Dcnnatologists 93% 
• Family Medicine Physicians 70% 
• Internal Medicine Physicians 52% 
- Physicians' diagnostic skills 
• Only 38% of prifllaly = ph}eoci•m ,,Mo;~ ldon1ifio14 o• I 
~of6mclanomas 
• 17% of these physicians categorized their training in this area 
as excellent or good 
Rationale 
What are we doing here? 
*Primary Care Physicians are not 
counseling high risk patients about skin 
cancer prevention 
- Family Physicians counseled high risk patients 
24% of the time 
-Internal Medicine Physicians counseled high 
risk patients 7:7% of the time 
Goals 
What do we want to learn? 
*Skin Cancer prevention and detection is 
important 
*GOALS of Presentation 
-Increase primary care physicians' knowledge 
about skin cancer 
-Increase primary care physicians' skills in 
primary and secondary prevention strategies 
-Improve primary care physicians' attitudes 
about putting skin cancer prevention into 
practice 
1 
Epidemiology 
Melanoma 
*Malignant melanoma is increasing in 
incidence more rapidly than any other 
cancer. 
*Current data estimates that in the year 2000 
I in 74 in the United States will develop 
malignant melanoma in their lifetime, 
-compared with 1 in 1500 in 1935. 
Epidemiology 
Melanoma 
*Death from melanoma may occur 
relatively early in adult life 
-Most common cause of cancer: 25-29 yrs 
-Second leading cause. of years of life loss to 
any adult-onset cancer 
*Long term survival in people with 
metastasis is dismal 
- Chemotherapy has poor results 
Secondary Prevention 
Detection 
*What do benign lesions that may be 
mistaken for skin cancer look like? 
*What do pre-cancerous lesions look like? 
Epidemiology 
Melanoma 
*At the current rate, the incidence of 
melanoma will DOUBLE every decade 
*It is believed that the incidence of 
melanoma is UNDER-reported by 20% 
*It is estimated that the cost for treating 
melanoma will be greater than $5 billion in 
the year 2000 
What is the good news? 
and Mortality from skin cancer 
can be reduced by your actions 
*S:ec<mdaryPrevention (Early Detection) 
- 5-year survival rate is estimated as 
• > 96% for melanomas that are thin (<0.75mm deep) 
• 47% for those that are thicker (>4rnm deep) 
*l'rirnaryPrevention (Counseling, Education) 
Secondary Prevention 
Detection 
*Primary Care Physicians have difficulty 
diagnosing skin cancer 
- Accuracy of skin cancer diagnosis by specialty 
• Dmnatologists 93% 
• Family Medicine Physicians 70% 
• Internal Medicine Physicians 52% 
- Physicians' diagnostic skills 
• Only 38% of pritrUDY care physicians emrcctly identified 4 
mon: of 6 melanomas 
• 17% ofthdC physicians categorized their training in this area 
as excellent or good 
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Se£~ondwy Prevention 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
-Nevus 
- Seborrheic keratosis 
- Pigmented basal cell carcinoma 
.-Actinic (solar) lentigo 
-Angioma 
- Dermatofibroma 
- Freckles/Caf6-au-lait spot 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
5 
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Secondary Prevention 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
- Cherry Angioma 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
Secondary Prevention 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
- Caf6-au·lait spot 
- won ein:umserilled lal8l' O:·!Omm) tiD rtQ<;II]es 
- IO.lS%oflh•I"'Pololi..awilll!>. .. _ 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
- Dennatofibroma 
Slow gmwingltllllld Ul IMll fumll!ll.blk! wi!h 
a dennal campmenltbal is small wilh well 
~=ledbonlm. 
What does skin cancer look like? 
*Differential Diagnosis for Melanoma: 
- Freckles/Ephelides 
s-11 ~l'P"'P;-10<1- !i>-...1= ,..O>poood ...... ra.. u;, 
Larpollllll>o,.oflioolclaon-olo<twi!lo-...lr!dtof11W1laaomo 
Sec:ondmyPrevention 
What does skin cancer look like? 
*F're<:ur:sor lesions of malignant melanoma 
-Dysplastic nevus 
- Large congenital nevi 
- Lentigo maligna 
* F're<:ur:sor lesions of squamous cell 
carcinoma 
- Actinic keratosis 
l 
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- Should screening be done? 
- Who should do the screening? 
- Who should be screened? 
- How often should screening be done? 
*Compelling rationale to screen for skin cancer: 
- Increasing incidence and mortality rate 
- Long asymptomatic period during which curability is 
high 
• 99% of melanomas found through physician 
screening are <1.5 em, which lends to much better 
prognosis for these patients 
• Early removal can reduce morbidity/mortality 
- An aceeptable, safe, and inexpensive screening test 
exists (the skin exam) 
Secondary Prevention 
Screening: Current Evidence 
*Skin cancer screening for high risk patients is 
cost-effective 
- Analysis by Freedberg et at. showed that physician 
screening of high risk patients cost 
• $19,170 per Year of Life Sand (YLS) 
- For comparison, screening with 
• Pap smear every three years eosts $46, 410/YLS 
• Mammogram every year for 
women age 55-65 costs $32:,1311/YlS 
i~econaa~rrevenuon 
Screeninr< Recommendations 
Group Screening method Frequency 
American Academy of *Self-examinations *Periodically 
Dennatology *Complete skin exam by *Annually 
physician 
American Cancer *Self-examinations *Every month 
Society *Complete skin exam by *Age 20-39: q3 yrs 
physician Age >39: annuaJiy 
U.S. Preventative *Insufficient evidence to *NIA 
Services Task Fon:e recommend for or against 
routine skin examinations 
American Academy of *Self-examination *Every six months 
Family Physicians *Complete skin exam by 
a physician for high risk *Periodic 
Secondary Prevention 
Current Evidence 
*No studies have clearly shown that 
screening the general population for skin 
cancer is beneficial or cost-effective. 
*Recent studies have shown that screening 
programs targeting high-risk individuals 
can have beneficial effects and are cost-
effective. 
Secondary Prevention 
Who is at risk? 
"Very High Risk": 
- Personal history of skin cancer (RR 2-8) 
- Family history of skin cancer (RR 2·8) 
- PersoD.al history of precursor lesions: (RR 7-70) 
• Large congenital nevus (>.Scm) 
• Dysplastic/atypical nevus 
• Lentigo maligna 
• Actinic keratosis 
' 
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Secondary Prevention 
.Decision 
*The ART of Basic Skin Cancer Triage 
*Algorithm developed by Martin 
Weinstock, MD, PhD to help physicians 
triage patients with skin lesions 
I~AUUII .... I 
1 ............. .. 
... ····~ ·~·•"> 
PRIMARY PREVENTION: 
Goals 
*Increase patierit knowledge 
*Change patient attitudes 
*Improve patient behaviors 
*Decrease morbidity and mortality 
Secondary Prevention 
Decision Making 
*When presented with a lesion, there are 3 
broad actions that a physician can take 
- ACT: Further evaluation needed 
• Biopsy in office, consider referral to a 
dennatologist, establish a monitoring plan 
- REASSURE: Give patient general advice 
about skin cancer and early detection 
- TRACK: Reevaluate at a later time to see if 
lesion has changed 
Secondary Prevention 
Conclusions 
*Early detection is a crucial element in 
decreasing the morbidity and mortality 
from skin cancer 
*Screening high risk patients can have 
beneficial effects and is cost-effective 
*Applying the Basic Skin Cancer Triage 
Algorithm can aid primary care physicians 
in decision making 
Primary Prevention: 
Current Knowledge 
very little about skin cancer (1995su:vey) 
-Only 1/3 of the adults knew melanoma was a skin cancer 
- 50% of men and 35% of women did not know the term 
melanoma 
- Only 26% oftbe adults knew early signs of melanoma 
are many misconceptions about sun exposure 
and skin cancer 
- Adults often think there is not risk from the sun during the winter. 
- Many adults believe that sun exposure is not harmful if you 
gmdually tan to "build-up resistance." 
I 
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Primary Prevention: 
PHYSICIAN RESPONSIBILTY 
*Patients have shown interest in counseling 
from physicians 
*Physician counseling has been shown to 
reduce patient tanning practices 
*Physician counseling has also been shown 
to increase the use of protective clothing 
by patients 
Putting Prevention into Practice 
*Targeting High Risk Patients 
*Prevention Systems 
Putting Prevention into Practice 
IdentifYing "high risk" groups 
*MacKie Questionnaire: Patients can identify 
themselves 
r:t - Four independent risk factors • 1-Freclding 
• 4- histOI)' of episodes ofsevere sWiburns ! 
- A score of>= 3 places the patient in a 'high risk' 
category 
• 2->20moleson!ilcin 
• 3- presence of atypical nevi 
- High risk patients should have total skin exam, 
counseling, and follow up 
*Physician identification during new patient 
interviews 
Putting Prevention into Practice 
*Barriers to Screening and Counseling: 
- Lack of time 
- Lack of expertise 
- Distraction by other health issues 
-Lack of positive feedback 
- Perception of inadequate reimbursement for 
time spent on preventive care 
Putting Prevention into Practice 
IdentifYing "high risk" groups 
*RISK FACTORS: 
-AGE 
- Cumulative sun exposure 
- Fair skin 
- History of blistering sun burns 
- Family or personal history of skin cancer 
- Precursor Lesions+ Dysplastic Nevi 
- Large number of common moles 
- Freckles 
- Exposure to UV radiation 
- Immune suppression 
Pu,tting P.revent'ion into Practice: 
PrE!Vel~ticm Systems 
*"Once I identify high risk patients and 
proceed with the TSE and counseling 
(and/or referral), how do I track them?" 
*"Flagging" high risk patients 
- Problem lists 
-Stickers 
- Reminders on computerized systems 
13 
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Basic Skin Cancer Triage Algorithm 
(from Weinstock eta!, 1996) 
Patients that are "very high risk" and do not have a 
plan for monitoring established by a dermatologist. 
Lesions that meet clinical criteria 
for benign lesions typical of: 
• seborrheic keratosis 
REASSURE+ • dermatofibroma 
REASSURE •. 
(But reevaluate if 
not gone in a month) 
REASSURE ~ 
REASSURE ~ 
• dermal nevus 
• cherry angioma 
• freckle/lentigo/cafe-au-lait spot 
Lesions that are: 
• Eroded, ulcerated, bleeding, or crusted > 3 weeks 
• Translucent papules with telangiectasia 
• Keratotic lesions on the face, ears, lips, or genitalia that 
are not typical sebortheic keratoses 
Lesions that are less than 3mm, absolutely flat, 
and no change by observation or history. 
Lesions that are: 
• Asymmetrical 
• Irregularly bordered 
• Multicohred or irregularly pigmented 
• Changing in size, shape, surface, or color 
Lesions that are black on people whose 
non-sun exposed skin is white or light tan. 
Small(< 6mm) lesions if they have not changed 
lhi~rtorically or by observatbn (and rot satisfied 
any of the above criteria for "act''). 
TRACK 
ACT 
LEGEND 
YES= ~ 
• NO=. 
• ACT 
I ACT 
• ACT 
~-
I 
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The ART of Basic Skin Cancer Triage 
ACT: 
Further evaluation needed (e.g. refer to dermatologist, bilpsy, counseling or other intervention.) 
REASSURE: 
Give patient general advice regarding skin cancer preventiln and early detection. 
TRACK: 
Reevaluate at 2 months and again at 6 months. If change occurs before or at scheduled follow-up, 
then "ACT'. Annual follow-up is indicated in the absence of a monitoring plan established by 
a dermatologist Photography may be helpful Encourage patient to return for reevaluation promptly 
if any change :i; noted. 
Very high risk*: 
Personal h:i;tory of melanoma, eight moles at least 6mm in diameter, or more than one genetically 
related family member with melanoma. 
Changing: 
Changilg in size, shape, surface, or color within the past year. This includes new lesions and 
excludes 1) slight increase in size of multiple moles in children or on expandingbodyparts (e.g. the 
abdomen of pregnant woman) and 2) similar concurrent darkening of multiple moles (e.g. with 
tanning or pregnancy). Simultaneous changes in size or color of multiple moles, from benign causes 
influence all moles in the affected area. 
Benign, typical of seborrheic keratosis: 
Keratotic; sharp border; raised, typically appears "stuck-on"; hom cysts or milia-like cysts. 
Benign, typical of dermatofibroma: 
Firm papule, tan or light brown surface gradually fading into normal skin, completely symmetric and 
regular, diameter< lcm, skin dimples downward with hteral compressi>n (dermatofibromas are most 
frequent on thigh and legs). 
Benign, typical of dermal nevus: 
Soft, round or oval, and dome-shaped; sharply circumscribed; flesh colored; diameter< lcm. 
Benign, typical offreckle/lentigo!cafe-au-lait: 
Completely flat, uniform tan color. 
Benign, typical of cherry angioma: 
Rotmd papule, cherry red color,< 6mm in diameter. 
* Other persons for whom evaluation is recommended include those with anycongeni1al or very large Go: 
1.5cm) nevi, a history of dysplastic/atypic a1 nevi or lentigo maligna, five or more nevi at least 6mm io 
diameter, at least 50 nevi at least2mm io diameter, family history of melaooma, personal history of aoy 
skin cancer, more thao 20 facial or 40 total actinic keratoses, chronic immunosuppression (particularly 
organ traosplaot recipients), or genetic syndromes associated with high skio cancer risk (e.g., xeroderma 
pigmentosum aod basal cell nevus syndrome). 
Adapted from: Weinstock MA, et al. Basic skin triage for teaching melanoma detection. JAm A cad Dermato/1996; 
34:1 063-6 and Weinstock MAe! al Clinical diagnosis ofmolesvs melanoma JAMA 1998;280:881-2. 
Self Administered Melanoma Risk 
Stratification Questionnaire 
Risk Factors for scoring the risk of melanoma 
1. Does your skin have freckles Yes No 
--
>r a tendency to freckling? 
2. Does you skin have moles? None <20 >20 
3. Does you skin have any large Yes No Don't know_ 
--
moles with irregular edge or 
color? 
4. How many times in your life Never lor2 3+ 
-
--
have you had bad sunburns? 
This form can be used to allow patients to self select themselves into a high-risk group. 
This could be done while in a waiting room. 
Scoring: 
#!-Patient receives one point if answered yes 
#2-Patient receives one point if answered >20 
#3-Patient receives one point if answered yes 
#4-Patient receives one point if answereed lor 2 or 3+ 
If the overall score is 3 or 4, the patient is at high risk for melanoma and should receive 
further counseling and screening. 
This risk assessment tool was validated in the following study: 
Jackson A, Wilkinson C, August P. Can primary prevention or selective screening for 
melanoma be more precisely targeted through general practice? A prospective study to 
validate a self administered risk score. BMJ 1998;316:34-9 
This study showed that 8.7% of the people completing the survey scored 3 or greater. 
This 8.7% had median a excess risk of greater than 60 for melanoma. 
Appendix 2 
• Consent form 
• Survey 
• Pictures referenced in the survey 
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SCHOOL OF MEDICINE 
PROGRAM ON PREVENTiON 
IN EDUCATION AND 
PRACTICE 
Linda Kinsinger, MD, MPH 
Co-Director 
(lkins@med.unc.edu) 
Russell Harris_. MD, MPH 
Co-Director 
(rharris@med.unc.edu) 
AmyL. Ward 
Education Coordinator 
(alward@med.unc.edu) 
Leslie Gray 
Program Assistant 
(leslie_gray@med.unc.edu) 
The University of North Carolina 
at Chapel Hill 
CB# 7508, Wing D, Room 383 
Chapel Hill, NC 27599-7508 
Phone: (919) 966-4065 
Fax: (919) 966-7499 
WHAT IS THE PURPOSE OF TillS STUDY? You are invited to 
participate in a research study entitled "Early Detection and Prevention of Skin 
Cancer for the Primary Care Physician". The purpose of the study is evaluate 
the effectiveness of a curriculum to teach Primary Care Physicians knowledge 
and skills to allow them to better detect and prevent skin cancer. If this 
curriculum is effective, it will be instituted as a continuing medical education 
(CME) progranz for North Carolina physicians. You are being asked to 
participate because you are in an internal medicine or family medicine 
residency program in North Carolina. 
The study is being conducted by: 
Jeremy Bordeaux 
4th year medical student at Duke University School of Medicine 
Masters of Public Health student at UNC-Chapel Hill School of Public Health 
Phone# 336-209-4229 
Email: jsb3@duke.edu 
Cristy Parker 
4th year medical student at UNC-Chapel Hill School of Medicine 
Masters of Public Healfu student at UNC-Chapel Hill School of Public Health 
Phone# 919-260-2053 
Email: cristen _parker@med. unc. edu 
Linda Kinsinger, MD, MPH 
Assistant Professor-Department of Social Medicine 
Co-Director-School of Medicine Program on Prevention 
UNC School of Medicine 
Phone# 919-966-4065 
Email: lkins@med.unc.edu 
WHAT WILL I BE ASKED TO DO? Residency programs will be 
randomized to control or intervention group. Bofu groups will be asked to 
complete a questionnaire that will take about 5-l 0 minutes. This questionnaire 
will inquire about your knowledge, attitudes, and behavior toward skin cancer 
prevention and early detection. Following fue initial survey, the intervention 
group will be asked to receive a 50-minute presentation entitled "Early 
Detection and Prevention of Skin Cancer for the Primary Care Physician." 
The control group will have their normal noon conference wifuout the 
presentation. Two to three weeks later, bofu groups will be asked to fill out a 
similar post test questionnaire fuat will also take 5-l 0 minutes to complete. 
This post test questionnaire may be emailed to you if you are not present at the 
selected conference. After this follow up data is collected, fue residency 
programs fuat are in fue control group will have the opportunity to receive the 
50-minute presentation at their request. There are no costs or payments for 
participating. 
Skin Cancer Prevention Questionnaire 
Thank you very much for taking a few minutes to complete this survey. Because you are training to be 
an internal medicine or family physician, your answers to the following questions are important to us. 
**Please assign your questionnaire a four-digit unique identifier that you will remember: 
(i.e., the last four digits of your social security number or phone number) 
**Please record the same number on your consent form 
First, we are interested in what vou know about skin cancer. (Circle one) 
1) What is the most common cancer to present to a primary care physician? 
a. Lung 
b. Breast 
c. Colon 
d. Skin 
2) Which of the following is a pre-cancerous lesion? (Circle the one best answer) 
a. Seborrheic keratosis 
b. Dermatofibroma 
c. Actinic keratosis 
d. Cafe-au-lait spot 
e. Dermal nevus 
3) What is the most common type of skin cancer? 
a. Basal cell 
b. Squamous cell 
c. Dermatofibroma 
d. Melanoma 
4) What is the lifetime risk of developing melanoma in 2000? 
a. 1/34 
b. l/74 
c. 1/100 
d. 11194 
5) What is the 5-year survival rate for a melanoma that is less than I millimeter thick? 
a. 40% 
b. 50% 
c. 80% 
d. 95% 
6) What is the 5-year survival rate for a primary melanoma lesion that is >4 millimeters thick 
without known metastasis? 
a. 30% 
b. 50% 
c. 75% 
d. 95% 
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10)45 year old woman with lesion on her arm. (please see pictureD, attached) 
A) What is the most likely diagnosis for this lesion? 
a. Seborrheic keratosis 
b. Basal celi carcinoma 
c. Angioma 
d. Melanoma 
e. Nevus 
B) What would you do next? 
a. Act (biopsy and/or refer) 
b. Reassure the patient and provide counseling and education 
c. Track (Reevaluate in 2 months to look for changes in the lesion) 
d. Perform cryotherapy and follow up 
11) 55 year old male with lesion on his back. (please see picture E, attached) 
A) What is the most likely diagnosis for this lesion? 
a. Seborrheic keratosis 
b. Basal cell carcinoma 
c. Angioma 
d. Melanoma 
e. Actinic keratosis 
B) What would you do next? 
a. Act (biopsy and/or refer) 
b. Reassure the patient and provide counseling and education 
c. Track (Reevaluate in 2 months to look for changes in the lesion) 
d. Perform cryotherapy and follow up 
12) 47 year old woman with lesion on her leg. (please see picture F, attached) 
A) What is the most likely diagnosis for this lesion? 
a. Seborrheic keratosis 
b. Basal cell carcinoma 
c. Angioma 
d. Melanoma 
e. Nevus 
B) What would you do next? 
a. Act (biopsy and/or refer) 
b. Reassure the patient and provide counseling and education 
c. Track (Reevaluate in 2 months to look for changes in the lesion) 
d. Perform cryotherapy and follow up 
I 
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Please rate each statement from 1 to 5 (Circle one) 
Disagree Somewhat Neutral Somewhat Agree 
Disagree Agree 
18) Total body self exam (TBSE) is effective 1 2 3 4 5 
19) Patients do not appreciate efforts to provide 
information on TBSE 1 2 3 4 5 
20) Early detection of skin cancer can improve 
morbidity 1 2 3 4 5 
21) Early detection of skin cancer can improve 
mortality 1 2 3 4 5 l__ 
' 22) Physicians cannot be effective in helping 
patients decrease skin cancer risk 1 2 3 4 5 
-
' r 
23) Patients want counseling about skin cancer 
prevention 1 2 3 4 5 
k 
24) Physician advice is one of the best ways of 
• influencing a patient's decision to reduce 
' 
their risk 1 2 3 4 5 
25) Physician counseling about skin cancer 
cannot save lives 1 2 3 4 5 
~ 
' 26) I am confident in my ability to diagnose j 
skin lesions 1 2 3 4 5 ~ 
Please rate each statement from 1 to 5 
Never Infrequently Sometimes Often Almost 
Always 
During a visit with a 11atient who is 
"high risk" for develo11ing skin cancer: 
27) I perform a total body skin exam 1 2 3 4 5 
28) I ask about use of sunscreen 1 2 3 4 5 
29) I advice and counsel about skin 
cancer risk 1 2 3 4 5 
30) I provide resource materials on 
skin cancer 1 2 3 4 5 
Finally, we would like to know a bit about vou. (Circle One) 
42) Specialty: Internal Medicine I Family Medicine I other( specify) __ _ 
43) · Level in training: PG-1 I PG-2 I PGc3 I other( specify) __ _ 
44) Gender: MALE FEMALE 
45) Have you had a clinical dermatology rotation 
lasting greater than 2 weeks at any point during 
your medical or residency training? YES NO 
46) If you had a dermatology rotation, 
was this as a 
(Circle all that apply) 
47) Do you anticipate having a clinical 
dermatology rotation lasting greater than 
2 weeks prior to completing training? 
48) What are your career goals? 
Medical student (MSl, MS2, MS3, MS4) 
Resident (PG-1, PG2, PG3, PG4) 
Other (specify). ___ _ 
I have not had a dermatology rotation. 
YES NO 
Specialty _________ _ 
Primary Care 
Undecided 
Please list and elaborate on any issues you think wonld help primary care physicians to institute 
preventive practices or early detective practices in their day-to-day practices. L 
Thank you for completing this survey. 
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